3CJF image
Entry Detail
PDB ID:
3CJF
Keywords:
Title:
Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2008-03-12
Release Date:
2008-10-07
Method Details:
Experimental Method:
Resolution:
2.15 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Vascular endothelial growth factor receptor 2
Chain IDs:A
Chain Length:309
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSO A CYS S-HYDROXYCYSTEINE
Primary Citation
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor.
J.Med.Chem. 51 4632 4640 (2008)
PMID: 18620382 DOI: 10.1021/jm800566m

Abstact

Inhibition of the vascular endothelial growth factor (VEGF) signaling pathway has emerged as one of the most promising new approaches for cancer therapy. We describe herein the key steps starting from an initial screening hit leading to the discovery of pazopanib, N(4)-(2,3-dimethyl-2H-indazol-6-yl)-N(4)-methyl-N(2)-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine, a potent pan-VEGF receptor (VEGFR) inhibitor under clinical development for renal-cell cancer and other solid tumors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures